Effects of Galcanezumab on Healthcare Resource Utilization and Acute Medication Use in Patients with Migraine- Results from Two Global Phase 3 Clinical Trials
Abstract
Authors
JH Ford SA Foster HC Detke VL Stauffer DD Ruff SK Aurora